ArticleDiabetes2013

Direct effects of PPARα agonists on retinal inflammation and angiogenesis may explain how fenofibrate lowers risk of severe proliferative diabetic retinopathy.

Steven F AbcouwerPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.